Q1 FY27 snapshot
Announcement Date5-Aug-26
Revenue (Top Line)₹228.25 Cr
Net Profit (Bottom Line)₹13.13 Cr
Earnings Per Share (EPS)₹9.19
Expenses₹195 Cr
Net profit margin (calculated)5.8%
Fredun Pharmaceuticals Ltd. (539730) Quarterly Results: Q1 FY27
Quick answer: Fredun Pharmaceuticals Ltd. (NSE: 539730) reported Q1 FY27 revenue of ₹228.25 Cr and net profit of ₹13.13 Cr, with earnings per share (EPS) of ₹9.19, announced on 5-Aug-26.
That works out to a net profit margin of about 5.8% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Fredun Pharmaceuticals Ltd.'s Q1 FY27 results
Revenue of ₹228.25 Cr is what Fredun Pharmaceuticals Ltd. earned before costs. Net profit of ₹13.13 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 5.8%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Fredun Pharmaceuticals Ltd. results FAQs
What were Fredun Pharmaceuticals Ltd.'s Q1 FY27 results?
Fredun Pharmaceuticals Ltd. (NSE: 539730) reported Q1 FY27 revenue of ₹228.25 Cr and net profit of ₹13.13 Cr, with earnings per share (EPS) of ₹9.19, announced on 5-Aug-26.
What is Fredun Pharmaceuticals Ltd.'s EPS for Q1 FY27?
Fredun Pharmaceuticals Ltd.'s earnings per share for Q1 FY27 was ₹9.19. EPS is net profit divided by the number of outstanding shares.
When did Fredun Pharmaceuticals Ltd. announce its Q1 FY27 results?
Fredun Pharmaceuticals Ltd. announced its Q1 FY27 results on 5-Aug-26.
What is Fredun Pharmaceuticals Ltd.'s net profit margin?
On the reported figures, Fredun Pharmaceuticals Ltd.'s Q1 FY27 net profit margin is about 5.8% (net profit ÷ revenue).